Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Troy J. Kemp
Observed names:
Troy J. Kemp,
Troy J Kemp
Institution:
Government of the United States of America
Observed institutions:
Government of the United States of America,
Frederick National Laboratory for Cancer Research,
Leidos Biomedical Research Inc. (United States)
ORCID:
0000-0002-1197-7525
Observed ORCID:
0000-0002-1197-7525
OpenAlex ID:
A5036588773
HPV16/18 antibodies 16-years after single dose of bivalent HPV vaccination: Costa Rica HPV vaccine trial
2024
·
Carolina Porras
, Byron Romero
, et al.
·
JNCI Monographs
·
46
PDF
Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9–14 years: results of the long-term extension of the DoRIS randomised trial
2025
·
Deborah Watson-Jones
, John Changalucha
, et al.
·
The Lancet Global Health
·
25
WHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58
2024
·
Troy J. Kemp
, Gitika Panicker
, et al.
·
npj Vaccines
·
17
PDF
Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9–14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial
2025
·
Tsiri Agbenyega
, Anne E Schuind
, et al.
·
The Lancet Infectious Diseases
·
16
Humoral immune responses to the second dose of a COVID-19 mRNA vaccine in cancer patients undergoing treatment
2025
·
Christine M. Dang
, Troy J. Kemp
, et al.
·
Human Vaccines & Immunotherapeutics
·
2
PDF
Blood collection tube and anticoagulant influence on SARS-CoV-2 antibody and avidity levels
2024
·
Nicholas C. Castro
, Jimmie Bullock
, et al.
·
Heliyon
·
2
Immunogenicity of one and two doses of Gardasil®9 in Tanzanian girls in the DoRIS Trial
2025
·
Troy J. Kemp
, Kathy Baisley
, et al.
·
npj Vaccines
·
1
PDF
Neutralizing antibody responses to the primary series of a COVID-19 mRNA vaccine in the cancer cohort under active treatment
2025
·
Huijing Xue
, Troy J. Kemp
, et al.
·
Human Vaccines & Immunotherapeutics
·
1
Analytical Evaluation of SARS CoV 2 Spike Protein Stability across Routine Aliquoting and Freezing Methods
2026
·
Ruturaj R. Masvekar
, Gabriela Mansano Do Nascimento
, et al.
·
SSRN Electronic Journal
Development and calibration of an HPV serology secondary standard for measuring antibody responses in HPV vaccine trials: a preliminary report
2025
·
Troy J. Kemp
, Dianna E. Wilkinson
, et al.
·
Microbiology Spectrum
Cancer and COVID-19: A review of immune insights and partnerships to inform public health strategy
2025
·
Heidi Hempel
, Huijing Xue
, et al.
·
International Journal of Infectious Diseases
PDF
Immunogenicity and Safety of Escherichia Coli-Produced Bivalent Human Papillomavirus Vaccine in Girls 9–14 Years of Age in Low- and Middle-Income Countries: Final Data of Randomized Controlled Trial
2024
·
Tsiri Agbenyega
, Anne E. Schuind
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
12
Citation count:
110
H-index:
4
I10-index:
4
Year
Topic
Type